Ergoteles LLC Chemo Centryx, Inc. Transaction History

Ergoteles LLC

$68.2 Billion
Q3 2023

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $8.27 Million - $19.3 Million	373,020 New	373,020 $19.3 Million
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $1.29 Million - $2.83 Million	-69,920 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $921,545 - $1.39 Million	69,920 New	69,920 $1.2 Million
Q2 2021 Aug 12, 2021	SELL	$9.59 - $50.88 $149,604 - $793,728	-15,600 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$49.53 - $68.4 $772,668 - $1.07 Million	15,600 New	15,600 $799,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.